| Total | NAFLD+ CT | NAFLD+ US | P-value |
---|---|---|---|---|
Male | 34 (73.91) | 9 (100) | 16 (69.57) | .002* |
Age, (range) | 47.91 (25; 68) | 49.55 (37; 57) | 48.39 (33; 67) | .71§ |
CCD C, n (%) | 9 (19.57) | 3 (33.33) | 5 (21.74) | .45* |
Duration of HIV infection | 178.26 (52; 278) | 172.11 (52; 255) | 185.68 (52; 278) | .60§ |
CD4 cell count | 554 (153; 1197) | 590 (290; 760) | 539 (180; 1197) | 1†|
Log10 VL | 2.10 (1.60; 4.72) | 2.22 (1.60; 4.50) | 2.23 (1.60; 4.72) | .98§ |
NRTI cumulative exp, months (range) | 187.97 (8; 614) | 182.55 (22; 317) | 196.87 (22; 614) | .78§ |
NNRTI cumulative exp, months (range) | 47.18 (1; 131) | 35 (12; 82) | 32.81 (1; 111) | .85§ |
PI cumulative exp, months (range) | 68.73 (1; 593) | 59.44 (21; 120) | 81.82 (1; 593) | .59§ |
AST/ALT | 1.00 (0.51; 2.1) | .86 (0.51; 1.45) | .94 (0.51; 1.54) | .55§ |
Waist | 86.54 (69; 113) | 90.11 (78; 113) | 89.58 (77; 113) | .90§ |